PROTECT: imPROving prenaTal carE During ConfinemenT

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Completed
CT.gov ID
NCT04368832
Collaborator
(none)
108
1
6.8
16

Study Details

Study Description

Brief Summary

This study is a non-randomized, quasi-experimental, monocentric study comparing two prenatal monitoring modes in low-risk pregnancy: including at least one remote consultation (phone or teleconsultation) versus face-to-face adapted to confinement. The quality of care perceived by the pregnant women were evaluated according to monitoring modes set up during the COVID-19 pandemic confinement period. The women included planned to give birth at the regional academic Maternity of Nancy, France.

Condition or Disease Intervention/Treatment Phase
  • Other: Remote consultation

Detailed Description

The emergency confinement measures deployed by most industrialized countries governments to limit the impact of the coronavirus disease 2019(COVID-19) pandemic resulted in rapid and unpredictable changes in methods of obstetric monitoring. International and French government recommendations called for a reorganization of mandatory monitoring, particularly for low-risk pregnancies (limit the presence of the coparent during follow-up consultations and implement remote consultations). The potential impact of this reorganization on care perception, probably increased by the context of an unprecedented economic, social and health crisis, is unpredictable. In the absence of a previous event of comparable importance, it is impossible to anticipate differences in satisfaction with antenatal management and in stress level between women exposed to the two types of monitoring. Many factors can influence the perception of care quality, such as the socio-economic environment and the level of health literacy, that is, the individual's ability to find information on health, to understand and use this information to improve his own health or develop autonomy in health care system.

The objective of this study is to determine which type of monitoring is better perceived by pregnant women, the factors associated with this perception and the links with the level of knowledge and mastery of women regarding reproductive health and digital tools.

Study Design

Study Type:
Observational
Actual Enrollment :
108 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
ImPROving prenaTal carE During ConfinemenT: Impact of Confinement on the Quality of Prenatal Care Perceived in Low-risk Pregnancy
Actual Study Start Date :
Apr 25, 2020
Actual Primary Completion Date :
Nov 17, 2020
Actual Study Completion Date :
Nov 17, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental group

During prenatal monitoring, at least one consultation by remote consultation (phone or teleconsultation)

Other: Remote consultation
One or more consultation is conducted by phone or teleconsultation during prenatal monitoring

Control group

Prenatal monitoring by face-to-face consultations adapted to confinement (absence of clinical signs or notion of travel, occupation, contact, clustering (TOCC), no attendant, limited movements inside the hospital and precautions of "droplet" and "contact" type)

Outcome Measures

Primary Outcome Measures

  1. Score of perceived quality of prenatal care [Through study completion, an average of 3 months, ie either at the beginning of the second or the third trimester of pregnancy, or during immediate postpartum care]

    score obtained with the Quality of prenatal care questionnaire (QPCQ) as close as possible after release from containment

Secondary Outcome Measures

  1. Level of stress during pregnancy [Through study completion, an average of 3 months, ie at the beginning of the second and the third trimester of pregnancy, and during immediate postpartum care]

    Perceived stress measured with Perceived Stress Scale-10 (PSS-10) scale

  2. level of health and digital literacy [Through study completion, an average of 3 months, ie at the beginning of the second and the third trimester of pregnancy, and during immediate postpartum care]

    level of health and digital literacy evaluated with Health Literacy Questionnaire (HLQ) and eHealth Literacy Questionnaire (eHLQ) questionnaire

  3. Obstetrical outcomes [Through study completion, an average of 6 months, ie at the end of postpartum care hospitalization]

    core set of outcomes for maternity care

  4. Characteristics of medical supervision during pregnancy [Through study completion, an average of 6 months, ie throughout the period of pregnancy]

    Number of remote, face-to-face or emergency consultations during pregnancy and requester of each consultation (patient or practitioner)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Pregnant woman eligible for type A or A1 follow-up according to the French Health Authority "Haute Autorité de Santé" (HAS) (low-risk pregnancy)

  • Having consulted at least one practitioner (midwife or physician) during the COVID-19 national confinement period

  • Gestational age > 7 weeks of amenorrhea on 17th March 2020, at the beginning of the national confinement period in France

  • having received complete information on the organisation of this research and not opposed to participation and exploitation of her data

  • Childbirth expected in the regional academic Maternity of Nancy

  • Member of or beneficiary of a social security scheme

  • Speaking French and able to complete a self questionnaire or having the possibility of being assisted

Exclusion Criteria:
  • Not understanding French

  • Multiple pregnancy

  • Request for voluntary termination of pregnancy

  • Discovery or suspicion of congenital malformation

  • Under protection of justice, guardianship or trusteeship

  • Deprived of liberty by judicial or administrative decision

  • Undergoing psychiatric care under sections L. 3212-1 and L. 3213-1 of french law (hospitalization without consent).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maternité Régionale Universitaire de Nancy Nancy France 54035

Sponsors and Collaborators

  • Central Hospital, Nancy, France

Investigators

  • Principal Investigator: Gaëlle Ambroise, CHRU Nancy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mme Gaëlle AMBROISE, Mrs, Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT04368832
Other Study ID Numbers:
  • 2020-A01023-36
First Posted:
Apr 30, 2020
Last Update Posted:
Mar 22, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mme Gaëlle AMBROISE, Mrs, Central Hospital, Nancy, France

Study Results

No Results Posted as of Mar 22, 2022